CoenzymeQ10 ( DrugBank: - )
1 disease
| 告示番号 | 疾患名(ページ内リンク) | 臨床試験数 | 
|---|---|---|
| 21 | ミトコンドリア病 | 1 | 
21. ミトコンドリア病
臨床試験数 : 33 / 薬物数 : 42 - (DrugBank : 32) / 標的遺伝子数 : 47 - 標的パスウェイ数 : 67
| No. | TrialID | Date_ enrollment  | Date_ registration  | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor  | Secondary_ sponsor  | Recruitment_ Status  | Inclusion_ agemin  | Inclusion_ agemax  | Inclusion_ gender  | Target_ size  | Phase | Countries | 
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00432744 (ClinicalTrials.gov)  | January 2007 | 6/2/2007 | Phase III Trial of Coenzyme Q10 in Mitochondrial Disease | Phase 3 Trial of Coenzyme Q10 in Mitochondrial Disease | Mitochondrial Diseases | Drug: CoenzymeQ10;Drug: Placebo | University of Florida | FDA Office of Orphan Products Development;Food and Drug Administration | Completed | 12 Months | 17 Years | All | 24 | Phase 3 | United States;Canada |